Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADiTx Therapeutics

1.48
-0.0600-3.90%
Volume:68.02K
Turnover:102.37K
Market Cap:3.14M
PE:0.00
High:1.55
Open:1.54
Low:1.47
Close:1.54
Loading ...

BRIEF-Appili Therapeutics Announces Submission Of US Federal Government Funding Proposals And Provides Corporate And Aditxt Transaction Update

Reuters
·
18 Mar

Appili Therapeutics Inc - Four New Funding Proposals, Totalling US$117.5 Mln, Submitted for Review

THOMSON REUTERS
·
18 Mar

Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update

GlobeNewswire
·
18 Mar

Aditxt Provides Business Status Overview and Announces Launch of Aditxt Weekly Update Starting Friday, March 21, 2025

Business Wire
·
17 Mar

ADiTx Therapeutics trading halted, news pending

TIPRANKS
·
15 Mar

Crude Oil Falls 1%; Dollar General Posts Upbeat Sales

Benzinga
·
14 Mar

Nasdaq Down Over 100 Points; US Producer Inflation Stalls In February

Benzinga
·
13 Mar

US Stocks Likely To Open Lower After A Brief Respite: 'Add Exposure To Equities' Amid Pullback, Says Expert

Benzinga
·
13 Mar

Aditxt’s Adimune to ship substances for product formulation of of ADI-100

TIPRANKS
·
06 Mar

Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of Adi-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome at the Mayo Clinic in the U.S.

THOMSON REUTERS
·
06 Mar

Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome at the Mayo Clinic in the U.S.

Business Wire
·
06 Mar

Aditxt subsidiary Persanta engages Dominary Securities for IPO

TipRanks
·
22 Feb

BRIEF-Aditxt Co's Unit Pearsanta Engaged Dominari Securities Llc As Lead Underwriter For Pearsanta's Planned IPO

Reuters
·
21 Feb

Aditxt: Co's Unit Pearsanta Engaged Dominari Securities Llc as Lead Underwriter for Pearsanta's Planned IPO

THOMSON REUTERS
·
21 Feb

Aditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025

Business Wire
·
21 Feb

Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time

Business Wire
·
13 Feb

BRIEF-Aditxt’S Board Of Directors Unanimously Approve Positioning Pearsanta For IPO To Support Global Launch Of Its Early Cancer Detection Platform

Reuters
·
13 Jan

Aditxt’s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of Its Early Cancer Detection Platform

THOMSON REUTERS
·
13 Jan

Aditxt Inc - to Explore Pearsanta IPO in 2025

THOMSON REUTERS
·
13 Jan

Aditxt’s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform

Business Wire
·
13 Jan